In the current tight economic times, it comes as no shock that federally funded programs, including research grants, should come under scrutiny. After all, we pay taxes that support those research grants, and nobody likes to see government waste. Unfortunately, this mindset can easily lead to attacking what appears to be easy targets.
By way of response to the criticisms, Josephine P. Briggs, NCCAM's director, stated, "The initial studies were driven by some very strong enthusiasms, and now we're learning about how to layer evidence and to do more basic science before testing a particular supplement in a large trial. There are a lot of negative studies in conventional medicine, and the government's outlay is small compared to drug company spending."